Changes in the use of end points in clinical trials for elderly cancer patients over time.

about

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Item

http://www.wikidata.org/entity/Q48582976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Changes in the use of end poin ...... rly cancer patients over time.

@en

Changes in the use of end poin ...... rly cancer patients over time.

@nl

type

Item

label

Changes in the use of end poin ...... rly cancer patients over time.

@en

Changes in the use of end poin ...... rly cancer patients over time.

@nl

prefLabel

Changes in the use of end poin ...... rly cancer patients over time.

@en

Changes in the use of end poin ...... rly cancer patients over time.

@nl

P1476

Changes in the use of end points in clinical trials for elderly cancer patients over time

@en

P2093

B You

http://www.w3.org/2001/XMLSchema#string

G Freyer

http://www.w3.org/2001/XMLSchema#string

H K Gan

http://www.w3.org/2001/XMLSchema#string

J Péron

http://www.w3.org/2001/XMLSchema#string

O Le Saux

http://www.w3.org/2001/XMLSchema#string

P2860

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals

Publication bias in clinical research

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials.

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.

On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?

Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.

Tolerance to chemotherapy in elderly patients with cancer.

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer

Evaluation of progression-free survival as a surrogate endpoint for survival in chemotherapy and targeted agent metastatic colorectal cancer trials.

P304

2606-2611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX354

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claire Falandry

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28961850

http://www.w3.org/2001/XMLSchema#string